Replimune Group Inc (NASDAQ: REPL) kicked off on Tuesday, up 4.82% from the previous trading day, before settling in for the closing price of $8.71. Over the past 52 weeks, REPL has traded in a range of $2.68-$17.00.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -14.85%. While this was happening, its average annual earnings per share was recorded -4.58%. With a float of $66.67 million, this company’s outstanding shares have now reached $78.40 million.
Replimune Group Inc (REPL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Replimune Group Inc is 15.01%, while institutional ownership is 99.17%. The most recent insider transaction that took place on Aug 15 ’25, was worth 49,157. In this transaction Chief Financial Officer of this company sold 9,154 shares at a rate of $5.37, taking the stock ownership to the 134,368 shares. Before that another transaction happened on May 20 ’25, when Company’s Director sold 32,279 for $8.06, making the entire transaction worth $260,169. This insider now owns 1,405,071 shares in total.
Replimune Group Inc (REPL) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.79 earnings per share (EPS), lower than consensus estimate (set at -0.72) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.51% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Take a look at Replimune Group Inc’s (REPL) current performance indicators. Last quarter, stock had a quick ratio of 6.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.61, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
The latest stats from [Replimune Group Inc, REPL] show that its last 5-days average volume of 2.41 million was inferior to 4.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 28.47%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 61.08%, which indicates a significant increase from 39.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.72 in the past 14 days, which was higher than the 0.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.27, while its 200-day Moving Average is $8.58. Now, the first resistance to watch is $9.60. This is followed by the second major resistance level at $10.06. The third major resistance level sits at $10.56. If the price goes on to break the first support level at $8.63, it is likely to go to the next support level at $8.13. Assuming the price breaks the second support level, the third support level stands at $7.67.
Replimune Group Inc (NASDAQ: REPL) Key Stats
The company with the Market Capitalisation of 716.19 million has total of 78,443K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -247,300 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -83,100 K.
